Indian drug regulators ordered Sun Pharma to halt eye-care drug production at its Assam plant over quality lapses, following the recall of 332 batches of ophthalmic products.
The post CDSCO asks Sun Pharma to halt eye-care drug production over quality lapses appeared first on Home Page.
